// App-Quantinova.ai

902 : Plasma Proteomic Analysis and Targeted Immunoassay Validation Identifies the Role of Endothelial Dysfunction in Development of ARDS, Thrombosis and Clinical Outcomes in Critically Ill COVID-19 Patients

Researchers

Presenter

  • P. Bhatraju

Principal Investigators

  • I. Stanaway

  • N. A. Sathe

  • A. SRIVASTAVA

  • R. Postelnicu

  • A. Andrews

  • M. Gonzalez

  • C. Kratochvil

  • V. Kumar

  • G. L. Anesi

  • D. Wyles

  • J. Broadhurst

  • D. Brett-Major

  • V. Mukherjee

  • J. Sevransky

  • D. Landsittel

  • S. A. Gharib

  • T. Uyeki

  • J. Cobb

  • J. M. Liebler

  • L. Segal

  • L. Evans

  • C. Mikacenic

  • M. Wurfel

Medical Centers

  • University of Washingon, Seattle, WA, United States

  • Kidney Research Institute, University of Washingon, Seattle, WA, United States

  • Biomedical Informatics, University of Pittsburgh, Pittsburgh, PA, United States

  • Society of Critical Care Medicine, Society of Critical Care Medicine, Mount Prospect, IL, United States

  • Pulmonary, Allergy, and Critical Care, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, United States

  • Pulmonary and Critical Care, New York Langone, New York City, NY, United States

  • Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA, United States

  • Univ of Southern California, Los Angeles, CA, United States

  • Translational Immunology, Benaroya Research Institute, Seattle, WA, United States

  • Pulmonary and Critical Care Medicine, University of Washington, Seattle, WA, United States

  • Pulmonary, Critical Care, and Sleep Medicine, University of Washington, Seattle, WA, United States

  • Global Center for Health Security, University of Nebraska Medical Center, Omaha, NE, United States

  • Division of Infectious Diseases, Denver Health Medical Center, Denver, CO, United States

  • Pulmonary, Allergy and Critical Care, Emory University, Atlanta, GA, United States

  • Department of Epidemiology and Biostatistics, School of Public Health, Bloomington, IN, United States

  • Department of Surgery, USC Keck School of Medicine, Los Angeles, CA, United States

  • Pulmonary and Critical Care, University of Washingon, Seattle, WA, United States

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

  • Infectious Diseases (ID)

  • Pulmonary/Respiratory Diseases

Disease

  • Vasodilation dysfunction

  • Venous thrombosis

  • Coronavirus disease

  • Acute lung injury

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Multicenter

  • Cohort

Phase

  • I

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final